Michael Mengel mostly deals with Pathology, Transplantation, Biopsy, Kidney transplantation and Kidney. Michael Mengel has included themes like Transplant glomerulopathy and Internal medicine in his Pathology study. His Transplantation study incorporates themes from Clinical trial, Intensive care medicine, Kidney disease and Urology.
His Biopsy research is multidisciplinary, relying on both Capillaritis, Prospective cohort study, Proteinuria and Histology. His Kidney transplantation research incorporates themes from Allograft rejection and Retrospective cohort study. His work carried out in the field of Kidney brings together such families of science as Creatinine, Inflammation, Immunology and Urinary system.
Pathology, Transplantation, Kidney, Biopsy and Internal medicine are his primary areas of study. His study in Pathology is interdisciplinary in nature, drawing from both Gene expression and Kidney disease. His studies deal with areas such as Immunology and Urology as well as Transplantation.
His work deals with themes such as Fibrosis, Inflammation, Urinary system and Creatinine, which intersect with Kidney. The study incorporates disciplines such as Glomerulonephritis and Disease in addition to Biopsy. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology, Oncology and Cardiology.
His scientific interests lie mostly in Pathology, Transplantation, Kidney, Kidney transplantation and Gene expression. His research integrates issues of Lung, Perfusion and Banff Classification in his study of Pathology. His Transplantation research is multidisciplinary, incorporating elements of Legislation, Intensive care medicine, Histocompatibility, Conflict of interest and Law legislation.
Kidney is a subfield of Internal medicine that Michael Mengel investigates. His Kidney transplantation study combines topics from a wide range of disciplines, such as Immunohistochemistry, Clinical trial and MEDLINE. The Gene expression study combines topics in areas such as Downregulation and upregulation, In vivo and Histology.
The scientist’s investigation covers issues in Pathology, Kidney transplantation, Transplantation, Clinical trial and Biopsy. He combines subjects such as Molecular pathology, Antibody detection, Perfusion, Heart transplantation and Kidney with his study of Pathology. His studies in Kidney integrate themes in fields like Kidney disease and Urology.
The various areas that Michael Mengel examines in his Kidney transplantation study include Interleukin 6, Immunology, microRNA, Fibrosis and Gene silencing. His study in the field of Renal allograft is also linked to topics like Rapid expansion. His Biopsy research is multidisciplinary, incorporating perspectives in Lung transplantation, Glomerulosclerosis and Interstitial fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
K. Solez;R. B. Colvin;L. C. Racusen;M. Haas.
American Journal of Transplantation (2008)
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence.
J. Sellarés;D. G. de Freitas;M. Mengel;J. Reeve.
American Journal of Transplantation (2012)
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN').
K. Solez;R. B. Colvin;L. C. Racusen;B. Sis.
American Journal of Transplantation (2007)
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions
M. Haas;B. Sis;L. C. Racusen;K. Solez.
American Journal of Transplantation (2014)
Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups
B. Sis;M. Mengel;M. Haas;R. B. Colvin.
American Journal of Transplantation (2010)
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
M. Haas;A. Loupy;C. Lefaucheur;C. Roufosse.
American Journal of Transplantation (2018)
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.
G. Einecke;B. Sis;J. Reeve;M. Mengel.
American Journal of Transplantation (2009)
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
A. Loupy;M. Haas;K. Solez;L. Racusen.
American Journal of Transplantation (2017)
The Renal Arterial Resistance Index and Renal Allograft Survival
Jörg Radermacher;Michael Mengel;Sebastian Ellis;Stephan Stuht.
The New England Journal of Medicine (2003)
Banff 2011 Meeting Report: New Concepts in Antibody‐Mediated Rejection
M. Mengel;B. Sis;M. Haas;R. B. Colvin.
American Journal of Transplantation (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: